NotebookLM is getting in a few more features before the holidays, including an upgrade to Gemini 3 and Data Tables. Google on Friday shared that “NotebookLM is OFFICIALLY built on Gemini 3!” This ...

Google's latest addition to its NotebookLM artificial intelligence research platform is a feature called Data Tables. The tool can collect and synthesize information across multiple sources into a ...

The unemployment rate remains low but rose to its highest level since 2021. The federal government released two major economic reports this week, easing a backlog of data pent up by the 43-day ...

Inside IBM’s main research center rises a maze of silver towers, each 22 feet tall. Through their vented flanks, you catch glimpses of blinking lights and the shadows of wires. The machine’s ...

International Business Machines Corporation (NYSE:IBM) is one of the Hot AI Stocks on Wall Street’s Radar. On December 9, Stifel analyst David Grossman raised the firm’s price target on the stock to ...

IBM is betting $11 billion that real-time data infrastructure will become as critical to AI deployments as databases were to enterprise applications. The company's just-announced acquisition of ...

IBM (IBM +0.26%) wants to be an artificial intelligence (AI) powerhouse. The tech giant is scooping up data-streaming dynamo Confluent (CFLT +0.30%) to add to its growing collection of AI-enablers.

IBM boosts AI portfolio with Confluent deal Offer price at 34% premium to Confluent's last close Deal to be funded with cash on hand, expected to close mid-2026 Acquisition will boost IBM's recurring ...

IBM has agreed to acquire Confluent for $11 billion. Confluent specializes in data and event streaming, enabling applications and AI agents to communicate without hard dependencies. IBM expects the ...

IBM is buying data infrastructure company Confluent for $11 billion in cash in a bid to bolster its data and automation products as ever more companies move their tech operations to the cloud and ...

IBM said Monday it’s buying data streaming platform Confluent in a deal worth $11 billion that will help bolster the technology company’s artificial intelligence strategy. The two companies said they ...

Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...